Abstract
Sixty out-patients with severe agoraphobia took part in a controlled prospective clinical trial of combinations of methohexitone-assisted and standard systematic desensitization and monoamine oxidase inhibitor. Severity of agoraphobia in terms of avoidance and anxiety was rated both by the patients themselves and by an independent assessor during the eight weeks of treatment.
The monoamine oxidase inhibitor produced a significant reduction in severity of anxiety but not of avoidance. Methohexitone-assisted systematic desensitization appeared to produce significantly greater improvement than either standard systematic desensitization or no systematic desensitization in both anxiety and avoidance. Assessors' ratings showed that the monoamine oxidase inhibitor used in conjunction with methohexitone-assisted systematic desnsitization produced slightly greater clinical improvement than the other treatment combinations.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Boulougouris, J. C., Marks, I. M.: Implosions (flooding)—a new treatment for phobias. Brit. med. J. 1969 II, 721–723
Cole, J. O., Jones, R. T., Klerman, G. L.: Drug Therapy. In: Spiegal E. A. (ed.): Progress in neurology and psychiatry 16, 539–574. New York: Grune and Stratton 1961
Dally, P.: Chemo-therapy of psychiatric disorders. London: Logus Press Limited 1967
Friedman, D. E.: A new technique for systematic desensitization of phobic patients. Behav. Res. Ther. 4, 139–140 (1966)
Friedmann, D. E.: Personal Communication (1969)
Friedman, D. E., Lipsedge, M. S.: Treatment of phobic anxiety and psychogenic impotence by systematic desensitization employing methohexitone induced relaxation. Brit. J. Psychiat. 118, 87–90 (1971)
Gelder, M. G., Marks, I. M., Wolff, H. H.: Desensitization and pyschotherapy in the treatment of phobic states. A controlled enquiry. Brit. J. Psychiat. 113, 53–73 (1967)
Gelder, M. G., Marks, I. M.: Severe agoraphobia: A controlled prospective trial of behaviour therapy. Brit. J. Psychiat. 112, 309–319 (1966)
Hussar, A. E., Pachter, M.: Myocardial infarction and fatal coronary insufficiency during electro-convulsive therapy. J. Amer. med. Ass. 204, 1004–1007 (1968)
Kelly, D., Guirguis, W., Frommer, E., Mitchell-Heggs, N., Sargant, W.: Treatment of phobic states with antidepressants, a retrospective study of 246 patients. Brit. J. Psychiat. 116, 387–398 (1970)
Mawson, A. B.: Methohexitone-assisted desensitization in treatment of phobias. Lancet 13, 1084–1086 (1970a)
Mawson, A. B.: Correspondence. Brit. J. Psychiat. 116, 117 (1970b)
Pare, C. M. B.: Toxicity of psychotropic drugs. Proc. roy. Soc. Med. 57, 757–758 (1964)
Rachman, S.: Phobias. Their nature and control. Springfield, Ill. Ch. C. Thomas 1968
Sargant, W., Slater, E.: An introduction to physical methods of treatment in Psychiatry. Edinburgh-London: Churchill Livingstone 1972
Salkind, M.: Personal Communication (1972)
Stern, R.: Personal Communication (1972)
Tyrer, P., Candy, J., Kelly, D.: Phenelzine in phobic anxiety: controlled trial. Psychol.Med. 1973 III, 120–124
Willcox, D. R. C., Gillon, R., Harer, E. H.: Do psychiatric outpatients take their drugs? Brit. med. J. 1965 II, 790–792
Yorkston, N. J., Sergant, H. G. S., Rachman, S.: Methohexitone relaxation for desensitizing agoraphobic patients. Lancet 11, 651–653 (1968)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lipsedge, M.S., Hajioff, J., Huggins, P. et al. The management of severe agoraphobia: A comparison of iproniazid and systematic desensitization. Psychopharmacologia 32, 67–80 (1973). https://doi.org/10.1007/BF00421708
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00421708